Odyssey Health (ODYY) Non-Current Assets (2016 - 2025)
Odyssey Health (ODYY) reported Non-Current Assets of $97149.0 for Q2 2025, down 99.28% year-over-year from $13.4 million in Q2 2024, and down 38.71% sequentially from $158505.0 in Q1 2025.
Odyssey Health (ODYY) Non-Current Assets (2016 - 2025) Analysis & Trends
Odyssey Health has disclosed Non-Current Assets across 10 years of filings, most recently posting $97149.0 for Q2 2025.
- Quarterly Non-Current Assets fell 99.28% year-over-year to $97149.0 in Q2 2025, while the trailing twelve-month figure through Jan 2026 was $97149.0 (down 99.32% YoY) and the FY2024 annual result came in at $529203.0, up 960.42% from the prior year.
- Non-Current Assets fell to $97149.0 in Q2 2025, from $158505.0 in the prior quarter.
- Across five years, Non-Current Assets topped out at $13.8 million in Q1 2024 and bottomed at $276.0 in Q4 2021.
- The 5-year median for Non-Current Assets is $49375.5 (2023), against an average of $1.6 million.
- Year-over-year, Non-Current Assets jumped 27597.13% in 2024 and plunged 99.28% in 2025.
- Odyssey Health's Non-Current Assets stood at $276.0 in 2021, then surged by 18213.04% to $50544.0 in 2022, then retreated by 3.13% to $48961.0 in 2023, then soared by 223.74% to $158505.0 in 2024, then tumbled by 38.71% to $97149.0 in 2025.
- According to Business Quant data, Non-Current Assets over the past three periods registered $97149.0, $158505.0, and $158505.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 67.41 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.47 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2.30 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 8.34 Bn |
| 10 | Odyssey Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 97,149.00 |
| Jan 31, 2025 | 158,505.00 |
| Oct 31, 2024 | 158,505.00 |
| Jul 31, 2024 | 529,203.00 |
| Apr 30, 2024 | 13.42 Mn |
| Jan 31, 2024 | 13.79 Mn |
| Oct 31, 2023 | 48,961.00 |
| Jul 31, 2023 | 49,905.00 |
| Apr 30, 2023 | 48,769.00 |
| Jan 31, 2023 | 49,790.00 |
| Oct 31, 2022 | 50,544.00 |
| Jul 31, 2022 | 43,260.00 |
| Apr 30, 2022 | 44,014.00 |
| Jan 31, 2022 | 44,906.00 |
| Oct 31, 2021 | 276.00 |
| Jul 31, 2021 | 414.00 |
| Apr 30, 2021 | 552.00 |
| Jan 31, 2021 | 689.00 |
| Oct 31, 2020 | 3,327.00 |
| Jul 31, 2020 | 5,965.00 |